ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Immunoglobulin G4-Related Disease is on this study

  • ClinicalTrials.gov files the study under Immunoglobulin G4-Related Disease.
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Immunoglobulin G4-Related Disease.
1 links0 made here, not in the record1 judgments1 judge (the rules as one: Rule based)1 record change seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07950267Real-world Evidence ofInebilizumab in IgG4-RDPeking Union Medical College Hnot yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 20 · ClinicalTrials.gov record · Version of 2026-11-20Version of 2026-11-20CONDITIONSImmunoglobulin G4-Related D…The registry's MeSH filing›As of now · Rule based · Main conditionMain condition

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Nov 20 · changes seen, not judgments
As of nowImmunoglobulin G4-Related DiseaseRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.